Robert J. Melder
22Patents
5h-index
26Co-inventors
69Inventor score
Filing activity: Aug 29, 1997 → Feb 2, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7753962B2 | Textured medical devices | Human Necessities | 41 | Active |
| US7223724B1 | Use of vascular endothelial growth factor to treat photoreceptor cells | Chemistry; Metallurgy | 17 | Expired |
| US7524501B2 | Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies | Chemistry; Metallurgy | 6 | Expired |
| US8678046B2 | Apparatus and methods for loading a drug eluting medical device | Human Necessities | 5 | Active |
| US6593112B1 | Polynucleotides encoding fibroblast growth factor 15 | Human Necessities | 5 | Expired |
| US10736692B2 | Neuromodulation and associated systems and methods for the treatment of cancer | Human Necessities | 3 | Active |
| US8951296B2 | Devices and methods for photodynamically modulating neural function in a human | Human Necessities | 2 | Active |
| US11116561B2 | Devices, agents, and associated methods for selective modulation of renal nerves | Human Necessities | 1 | Active |
| US11350992B2 | Neuromodulation and associated systems and methods for the treatment of cancer | Human Necessities | 1 | Active |
| US11304749B2 | Systems, devices, and associated methods for neuromodulation with enhanced nerve targeting | Human Necessities | 1 | Active |
| US8636811B2 | Drug eluting rolled stent and stent delivery system | Human Necessities | 1 | Active |
| US6368858B1 | Modulation of multicellular aggregates by pressure from growth in a matrix | Chemistry; Metallurgy | 0 | Expired |
| US12226142B2 | Devices, agents, and associated methods for selective modulation of renal nerves | Human Necessities | 0 | Active |
| US10695542B2 | Drug coated balloon | Human Necessities | 0 | Active |
| US9615948B2 | Drug eluting folded stent and stent delivery system | Emerging Cross-Sectional Technologies | 0 | Active |
| US8764777B2 | Endoventricular stay and delivery system | Human Necessities | 0 | Active |
| US6605441B1 | Antibodies against fibroblast growth factor 11 | Chemistry; Metallurgy | 0 | Expired |
| US12268438B2 | Systems, devices, and methods for modulating renal nerve tissue | Human Necessities | 0 | Active |
| US6010712A | Therapeutic use of bFGF to treat conditions involving adhesion of cytotoxic white cells to endothelium | Human Necessities | 0 | Expired |
| US7045496B1 | Use of vascular endothelial growth factor to treat photoreceptor cells | General | 0 | Revoked |
| US11844568B2 | Systems, devices, and associated methods for neuromodulation with enhanced nerve targeting | Human Necessities | 0 | Active |
| US11717343B2 | Systems, devices, and associated methods for neuromodulation in heterogeneous tissue environments | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.